Yongcong Yan

Department of Hepatobiliary Surgery, Sun Yat-sen University

Research Area

Biography

Yongcong Yan has not added Biography.
If you are Yongcong Yan and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 1	2025

Other Publications

Article	Year
The impact of liver resection on survival outcomes of hepatocellular carcinoma patients with extrahepatic metastases: A propensity score matching study. Cancer medicine\| PubMed ID: 30117307	2018
Hepatitis B virus X protein related lncRNA WEE2-AS1 promotes hepatocellular carcinoma proliferation and invasion. Biochemical and biophysical research communications\| PubMed ID: 30471857	2019
Development and external validation of prognostic nomograms in hepatocellular carcinoma patients: a population based study. Cancer management and research\| PubMed ID: 31118768	2019
Novel nomograms to predict lymph node metastasis and liver metastasis in patients with early colon carcinoma. Journal of translational medicine\| PubMed ID: 31182111	2019
Identification and validation of a prognostic four-genes signature for hepatocellular carcinoma: integrated ceRNA network analysis. Hepatology international\| PubMed ID: 31321712	2019
Ropivacaine via nuclear factor kappa B signalling modulates CD62E expression and diminishes tumour cell arrest. Journal of anesthesia\| PubMed ID: 31642986	2019
Integrated Nomograms for Preoperative Prediction of Microvascular Invasion and Lymph Node Metastasis Risk in Hepatocellular Carcinoma Patients. Annals of surgical oncology\| PubMed ID: 31773517	2020
HBx/ERα complex-mediated LINC01352 downregulation promotes HBV-related hepatocellular carcinoma via the miR-135b-APC axis. Oncogene\| PubMed ID: 32157216	2020
Integrated nomogram based on five stage-related genes and TNM stage to predict 1-year recurrence in hepatocellular carcinoma. Cancer cell international\| PubMed ID: 32368186	2020
A Novel Staging System to Forecast the Cancer-Specific Survival of Patients With Resected Gallbladder Cancer. Frontiers in oncology\| PubMed ID: 32850391	2020
PRL-3 facilitates Hepatocellular Carcinoma progression by co-amplifying with and activating FAK. Theranostics\| PubMed ID: 32929353	2020
Anti-oncogene PTPN13 inactivation by hepatitis B virus X protein counteracts IGF2BP1 to promote hepatocellular carcinoma progression. Oncogene\| PubMed ID: 33051595	2021
Research on the Potential Mechanism of Gentiopicroside Against Gastric Cancer Based on Network Pharmacology. Drug design, development and therapy\| PubMed ID: 33262572	2020
SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters. Cell death & disease\| PubMed ID: 34301921	2021
A Novel Prognostic Model for Oral Squamous Cell Carcinoma: The Functions and Prognostic Values of RNA-Binding Proteins. Frontiers in oncology\| PubMed ID: 34395233	2021
Correction: SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters. Cell death & disease\| PubMed ID: 34400616	2021
Molecular Targets of Ferroptosis in Hepatocellular Carcinoma. Journal of hepatocellular carcinoma\| PubMed ID: 34466409	2021
Construction and Validation of a Combined Ferroptosis and Hypoxia Prognostic Signature for Hepatocellular Carcinoma. Frontiers in molecular biosciences\| PubMed ID: 34977159	2021
INPP5F translocates into cytoplasm and interacts with ASPH to promote tumor growth in hepatocellular carcinoma. Journal of experimental & clinical cancer research : CR\| PubMed ID: 34996491	2022
Prognostic nomogram for predicting cancer-specific survival in patients with resected hilar cholangiocarcinoma: a large cohort study. Journal of gastrointestinal oncology\| PubMed ID: 35557567	2022
Circular RNA circSFMBT2 downregulation by HBx promotes hepatocellular carcinoma metastasis via the miR-665/TIMP3 axis. Molecular therapy. Nucleic acids\| PubMed ID: 36159591	2022
Analysis of the potential association between ferroptosis and immune in hepatocellular carcinoma and their relationship with prognosis. Frontiers in oncology\| PubMed ID: 36776357	2022
Retraction Note: HBx/ERα complex-mediated LINC01352 downregulation promotes HBV-related hepatocellular carcinoma via the miR-135b-APC axis. Oncogene\| PubMed ID: 37365220	2023
Application and Resistance Mechanisms of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma. Journal of hepatocellular carcinoma\| PubMed ID: 37457652	2023
Comparison of survival benefit and safety between surgery following conversion therapy versus surgery alone in patients with surgically resectable hepatocellular carcinoma at CNLC IIb/IIIa s... International journal of surgery (London, England)\| PubMed ID: 38353702	2024
SMYD4 monomethylates PRMT5 and forms a positive feedback loop to promote hepatocellular carcinoma progression. Cancer science\| PubMed ID: 38438251	2024
Integrated analysis reveals an aspartate metabolism-related gene signature for predicting the overall survival in patients with hepatocellular carcinoma. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico\| PubMed ID: 38472558	2024
Hepatitis B virus X protein represses expression of tumor suppressor PTPN18 in hepatocellular carcinoma. Molecular cancer research : MCR\| PubMed ID: 38787319	2024
A deep learning-based clinical-radiomics model predicting the treatment response of immune checkpoint inhibitors (ICIs)-based conversion therapy in potentially convertible hepatocelluar carc... International journal of surgery (London, England)\| PubMed ID: 40085751	2025
Multi-omics analysis identifies OSGEPL1 as an oncogene in hepatocellular carcinoma. Discover oncology\| PubMed ID: 40090949	2025
Integrated analysis reveals an immune evasion prognostic signature for predicting the overall survival in patients with hepatocellular carcinoma. Cancer cell international\| PubMed ID: 40102844	2025
March5-mediated Trim28 degradation preserves islet β-cell function in mice. Nature communications\| PubMed ID: 40750777	2025
mA-Modified circRAPGEF1 Interaction with IGF2BP3 Promotes Hepatocellular Carcinoma Progression via Reprogramming Aspartate Metabolism. Advanced science (Weinheim, Baden-Wurttemberg, Germany)\| PubMed ID: 40801445	2025